logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

AAC TECH (02018) spent HK$15.6602 million on August 24 to repurchase 400,000 shares.

date
17:34 24/08/2026
avatar
GMT Eight
AAC Technologies Holdings Inc. (02018) announced that on August 24, 2026, the company spent HKD 15.6602 million to repurchase 400,000 shares, at a buyback price ranging from HKD 38.56 to HKD 39.5 per share.
AAC TECH (02018) announced that on August 24, 2026, the company will spend HKD 15.6602 million to repurchase 400,000 shares, with a repurchase price ranging from HKD 38.56 to 39.50 per share.
Related Articles
HK Stock
AV CONCEPT HOLD (00595) spent HKD 1.294 million to repurchase 1 million shares on August 24.
HK Stock
LEAPMOTOR (09863) announced its interim results, with a profit attributable to shareholders of 208 million yuan, a year-on-year increase of 530.97%.
HK Stock
BAO PHARMA-B (02659): The clinical trial application for KJ015 injection (anti-HER2 bispecific antibody subcutaneous formulation) has been approved by the US FDA.
AV CONCEPT HOLD (00595) spent HKD 1.294 million to repurchase 1 million shares on August 24.
HK Stock
LEAPMOTOR (09863) announced its interim results, with a profit attributable to shareholders of 208 million yuan, a year-on-year increase of 530.97%.
HK Stock
BAO PHARMA-B (02659): The clinical trial application for KJ015 injection (anti-HER2 bispecific antibody subcutaneous formulation) has been approved by the US FDA.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.